Approving A Muscular Dystrophy Drug Ignites A Civil War At The FDA

September 20, 2016 | Yesterday, the Food and Drug Administration made history, approving a drug to treat Duchenne muscular dystrophy that works by targeting the genetic mutation at the root of the disease. The decision was unique for reasons that were not just scientific. Forbes